These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 2267573

  • 1. Peptide vaccines for viral diseases.
    Francis MJ.
    Sci Prog; 1990; 74(293 Pt 1):115-30. PubMed ID: 2267573
    [Abstract] [Full Text] [Related]

  • 2. [Development of viral vaccines].
    Mertens T.
    Immun Infekt; 1987 Nov; 15(6):197-202. PubMed ID: 3325407
    [Abstract] [Full Text] [Related]

  • 3. [New technology of vaccine production--international prospect of the development. Synthetic peptide vaccines and protein engineering].
    Aimoto S, Sakiyama F.
    Nihon Rinsho; 1987 Oct; 45(10):2349-54. PubMed ID: 3502349
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2.
    Francis MJ, Hastings GZ, Sangar DV, Clark RP, Syred A, Clarke BE, Rowlands DJ, Brown F.
    J Gen Virol; 1987 Oct; 68 ( Pt 10)():2687-91. PubMed ID: 2822846
    [Abstract] [Full Text] [Related]

  • 6. Towards antiviral oligopeptide vaccines.
    Niesters HG, van der Zeijst BA.
    Microbiol Sci; 1984 Jun; 1(3):55-8. PubMed ID: 6086077
    [Abstract] [Full Text] [Related]

  • 7. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC, Anderson E, Bootland LM, Chiou PW, Johnson M, Kim C, Mourich D, Trobridge G.
    Dev Biol Stand; 1997 Jun; 90():267-77. PubMed ID: 9270855
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New approaches in viral vaccine development.
    Brown F.
    Scand J Infect Dis Suppl; 1990 Jun; 76():39-46. PubMed ID: 1966307
    [Abstract] [Full Text] [Related]

  • 12. Antiviral cytotoxic T lymphocyte induction and vaccination.
    Rouse BT, Norley S, Martin S.
    Rev Infect Dis; 1988 Jun; 10(1):16-33. PubMed ID: 2451265
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vaccination, immunopathology, and immunity.
    Hotchin J, Hotchin LB.
    Science; 1991 Jul 12; 253(5016):210. PubMed ID: 1712986
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ, Morrison LA, Knipe DM.
    Virology; 2001 Sep 30; 288(2):256-63. PubMed ID: 11601897
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. From Jenner to genes--the next generation of virus vaccines.
    Brown F.
    Biochem Soc Symp; 1987 Sep 30; 53():75-84. PubMed ID: 3332769
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.